Insider Transactions in Q4 2021 at Outlook Therapeutics, Inc. (OTLK)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2021
|
Terry Dagnon Chief Operations Officer |
BUY
Open market or private purchase
|
Direct |
25,201
+2.12%
|
$25,201
$1.38 P/Share
|
|
Dec 06
2021
|
C Russell Trenary Iii CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
25,000
+41.67%
|
$25,000
$1.39 P/Share
|
|
Dec 03
2021
|
Jeff Evanson CHIEF COMMERCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
35,200
+2.9%
|
$35,200
$1.34 P/Share
|
|
Dec 03
2021
|
Terry Dagnon Chief Operations Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+0.87%
|
$10,000
$1.42 P/Share
|
|
Dec 02
2021
|
C Russell Trenary Iii CEO AND PRESIDENT |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$10,000
$1.4 P/Share
|
|
Dec 02
2021
|
Faisal Ghiath Sukhtian Director |
BUY
Open market or private purchase
|
Direct |
18,000
+32.14%
|
$18,000
$1.4 P/Share
|
|
Dec 02
2021
|
Yezan Munther Haddadin Director |
BUY
Open market or private purchase
|
Direct |
10,000
+25.0%
|
$10,000
$1.39 P/Share
|
|
Nov 29
2021
|
Ghiath M. Sukhtian Director |
BUY
Open market or private purchase
|
Indirect |
16,000,000
+36.5%
|
$16,000,000
$1.25 P/Share
|